Alloxantin
5,5'-dihydroxy-5,5'-bipyrimidinehexaone
CAS: 76-24-4
Molecular Formula: C8H6N4O8
Alloxantin - Names and Identifiers
| Name | 5,5'-dihydroxy-5,5'-bipyrimidinehexaone |
| Synonyms | Uroxin Uroxine NSC 7634 HSDB 2081 AI3-23206 ALLOXANTIN Alloxantin ALLOXANTIN, DIHYDRATE 5,5'-dihydroxy-5'-bibarbituricacid 5,5'-Dihydroxy-5,5'-bibarbituric acid 5,5'-Dihydroxy-5,5'-dibarbituric acid 5,5'-dihydroxy-5,5'-bipyrimidinehexaone 5,5'-Bibarbituric acid, 5,5'-dihydroxy- 5,5'-Dihydroxy-5,5'-bipyrimidinehexaone 5,5'-Bibarbituric acid, 5,5'-dihydroxy- (8CI) 5,5'-dihydroxy-5,5'-bipyrimidine-2,2',4,4',6,6'(1H,1'H,3H,3'H,5H,5'H)-hexone [5,5'-bipyrimidine]-2,2',4,4',6,6'(1h,1'h,3h,3'h,5h,5'h)-hexone,5,5'-dihydroxy (5,5'-bipyrimidine)-2,2',4,4',6,6'(1h,1'h,3h,3'h,5h,5'h)-hexone,5,5'-dihydroxy (5,5'-Bipyrimidine)-2,2',4,4',6,6'(1H,1'H,3H,3'H,5H,5'H)-hexone, 5,5'-dihydroxy [5,5'-Bipyrimidine]-2,2',4,4',6,6'(1H,1'H,3H,3'H,5H,5'H)-hexone, 5,5'-dihydroxy- (5,5'-Bipyrimidine)-2,2',4,4',6,6'(1H,1'H,3H,3'H,5H,5'H)-hexone, 5,5'-dihydroxy- |
| CAS | 76-24-4 |
| EINECS | 200-947-1 |
| InChI | InChI=1/C8H6N4O8/c13-1-7(19,2(14)10-5(17)9-1)8(20)3(15)11-6(18)12-4(8)16/h19-20H,(H2,9,10,13,14,17)(H2,11,12,15,16,18) |
Alloxantin - Physico-chemical Properties
| Molecular Formula | C8H6N4O8 |
| Molar Mass | 286.16 |
| Density | 1.7122 (rough estimate) |
| Melting Point | 250°C (dec.)(lit.) |
| Boling Point | 428.53°C (rough estimate) |
| Water Solubility | 2.9g/L(25 ºC) |
| Merck | 283 |
| Refractive Index | 1.6640 (estimate) |
Alloxantin - Risk and Safety
| Hazard Symbols | Xi - Irritant |
| Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
Alloxantin - Reference Information
| EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
| toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |
Last Update：2024-04-09 15:16:52
